In addition, the high expression of ANO1 is closely associated with the advanced clinical stages of prostate cancer and ovarian cancer, as well as poor pathological differentiation grades, suggesting that ANO1 expression levels can serve as an important indicator for predicting poor tumor prognosis (162, 168). This evidence concerns the gene ANO1 and Familial prostate cancer.